US/UK/Canada

Share

Quotes

We are very much looking forward to use the MR-compatible Delta4 Phantom+ at our Viewray MRIdian Linac as well as at our Elekta and Tomotherapy Linacs to further advance and streamline our patient QA.
Sebastian Klüter, PhD, Medical Physicist, Department of Radiation Oncology, Heidelberg University Hospital, Germany
The Delta4 Phantom+ MR is quick and easy to use and gives us confidence that our treatments are delivered just as intended.
Wilfred de Vries, Clinical physicist engineer, UMC Utrecht, The Netherlands.
C-Rad now starts to market their imaging-product in the field of quality assurance and thereby becomes a provider of downstream dosimetry. This means that we have to look upon C-Rad as a competitor to ScandiDos. Therefore we terminate the sales-cooperation in North America.
Görgen Nilsson, CEO ScandiDos
ScandiDos has a well-functioning organization in US since 6 years with main-office in Madison conducting sales and giving appreciated support to a relatively large customer base. We will now focus 100% on our own products on the North American market.
Görgen Nilsson, CEO, ScandiDos
Pick a time period -
Tags ( Active)

Leading centers all over the world select Scandidos’ Delta4 Phantom+ MR for their MR-linac programs

Since the introduction of the Delta4 Phantom+ MR, ScandiDos has impressed the market with a Quality Assurance solution for Elekta´s Unity and Viewray´s MRIdian and gained many prominent customers all over the world. ScandiDos has installations in over 10 countries and the next planned installation will be in Center Hospital Lyon-Sud.Flagship product for use in magnetic fieldsScandiDos, a world-leading company in quality assurance of modern radiation therapy, has developed a new version of its flagship product Delta4 Phantom+ for use in magnetic fields. By working closely with leading

ScandiDos first customer order on Delta4 Discover

ScandiDos new product Delta4 Discover, has received its first Purchase Order from end-customer in Japan. Delta4 Discover measures the radiation dose to the patient during cancer treatment and is complementary to the current product ScandiDos Delta4 Phantom, in daily use at almost 500 clinics worldwide for pre-treatment verification.Since more than 10 years, clinics using the latest achievements in radiation therapy e.g. IMRT and VMAT have lacked the ability to verify with direct measurements that the dose to the patient is administrated correctly. ScandiDos’ new product Delta4 Discover (

ScandiDos and C-RAD have decided to end the cooperation on the North American market

ScandiDos and C-Rad, two Uppsala-based companies both active in the field of radiation therapy, have decided to discontinue the sales cooperation on the North American market. With upcoming introduction of new products from both companies a partly competitive situation arises. Therefore the sales-cooperation was terminated.In June 2013 ScandiDos and C-Rad launched the cooperation on the North American market. The companies entered into a mutual distribution agreement for the other company's products. ScandiDos provide products in the field of dosimetry and quality assurance for radiation

C-RAD AB and ScandiDos AB are joining sales forces in the USA

Press release 2013-0624 ScandiDos AB and C-RAD AB are two Swedish companies working in radiation therapy. Both companies are developing and marketing innovative solutions to improve quality and precision when treating patients with cancer. The companies have decided to merge resources on the important US market with the objective to offer a complete program for high quality control to the clinics. C-RAD is in the US marketing and selling two different systems for use in advanced radiation therapy: The Catalyst system is based on a new generation hardware and software platform for

Unique collaboration advances positions for Swedish radiation therapy

Press release March 19, 2013 All Swedish university hospitals and seven leading specialist companies are establishing a national test bed to jointly drive the development of cancer treatment with radiation therapy, a field in which Sweden can become a world leader. Health care and industry have joined forces in a consortium and have held the first joint meeting in Linköping. Within three years the collaboration will result in a highly specialized national test bed for innovative radiation therapy. As radiation therapy becomes increasingly effective, the demand for quality assurance is

IBA Dosimetry and ScandiDos enters a partnership in USA and Canada to offer a complete range of solutions for Radiation Therapy plan verification

· IBA Dosimetry enters into non-exclusive distribution agreement for Scandidos’ Delta4®PT (Pre Treatment) for the US and Canada · Partnership offers clinical users to select patient treatment validation solution that best suits needs to maximize efficiency and minimize errors in radiation therapy treatment Schwarzenbruck-Germany/Uppsala-Sweden, 17 January, 2013 – IBA Dosimetry and ScandiDos, the two global innovation leaders in the field of dosimetry solutions and services for radiation therapy cancer treatment, jointly announce that the two companies have entered into a non-exclusive

ScandiDos opens office in China

Uppsala/Beijing, December 2012 Scandidos is proud to announce the opening of its new office in Bejing China. ScandiDos has opened an office in China to support the rapidly growing Customer base and our Distributor network with technical and commercial support. Our Distributors in China will continue to provide sales and after-sales support to our End Users. The office is lead by the China Manager Mr. Wei Song who has worked in the Radiotherapy business in China and internationally for more than 10 years.

There are no items matching the current filter
There are no more items matching the current filter
Back to top